More tools:Markets·Screener·Research·Chat

Aditxt, Inc. Common Stock (ADTX) Financial Statements

Aditxt, Inc. Common Stock
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00RDV1WT4
XNAS · usd
0.01▲ 0.00 (6.85%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value—
Trailing P/E—
Price / Sales
EV / Revenue—
EV / EBITDA—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt—
Trading Information
Previous Close0.01
Day's Range0.01 – 0.01
52-Week Range0.00 – 7.13
Volume17.8M
Avg Volume756.7M
Share Statistics
Shares Outstanding
Employees26
ExchangeXNAS
Listed2020-06-30
Share count as of May 20, 2026
Loading Income Statement…
Key questions about Aditxt, Inc. Common Stock (ADTX)
What is Aditxt, Inc. Common Stock's Market Cap?
Aditxt, Inc. Common Stock's Market Cap is $6.4K, based on as-reported figures from SEC (XBRL) filings.
What is Aditxt, Inc. Common Stock's Price / Sales?
Aditxt, Inc. Common Stock's Price / Sales is 0.4×, based on as-reported figures from SEC (XBRL) filings.
What is Aditxt, Inc. Common Stock's Revenue (TTM)?
Aditxt, Inc. Common Stock's Revenue (TTM) is $14.3K, based on as-reported figures from SEC (XBRL) filings.
What is Aditxt, Inc. Common Stock's Net Income (TTM)?
Aditxt, Inc. Common Stock's Net Income (TTM) is -$53.3M, based on as-reported figures from SEC (XBRL) filings.
What is Aditxt, Inc. Common Stock's EBITDA?
Aditxt, Inc. Common Stock's EBITDA is -$18.1M, based on as-reported figures from SEC (XBRL) filings.
What is Aditxt, Inc. Common Stock's Diluted EPS (TTM)?
Aditxt, Inc. Common Stock's Diluted EPS (TTM) is -65.37, based on as-reported figures from SEC (XBRL) filings.
What is Aditxt, Inc. Common Stock's EBITDA Margin?
Aditxt, Inc. Common Stock's EBITDA Margin is -126063.3%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022
REVENUE
Sales
YoY growth+1094.4%-86.6%-89.1%-97.7%
Cost of goods sold
Gross profit
% of revenue23.6%-7.3%2.1%-0.1%
OPERATING EXPENSES
General and administrative expenses $0 and $0 in stock-based compensation, respectively
Research and development $0 and $10,000 in stock-based compensation, respectively
Sales and marketing $0 and $0 in stock-based compensation, respectively—
Total operating expenses
% of revenue35897.1%1098718.4%419872.5%612788.2%
NET LOSS FROM OPERATIONS
% of revenue-35873.5%-1098725.6%-419870.3%-612788.3%
NET LOSS
% of revenue-133145.8%-1230882.6%-3236319.4%-736619.3%
NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTEREST
NET LOSS ATTRIBUTABLE TO ADITXT, INC. & SUBSIDIARIES
% of revenue-131159.8%-1432689.2%-3214626.3%-722789.6%
Net loss per share, basic (in Dollars per share)—
Net loss per share, diluted (in Dollars per share)—